कवर छवि

Antithrombotic therapy and clinical characteristics of patients hospitalized for nonvalvular atrial fibrillation in Galician internal medicine clinics

<p>This was a multicenter, prospective, observational study that assessed the characteristics of patients with Nonvalvular Atrial Fibrillation (NVAF) admitted to internal medicine units in Galicia, Spain, as well as the antithrombotic treatment prescribed prior to hospital admission.</p>

में बचाया:

ग्रंथसूची विवरण
मुख्य लेखकों:	Jose Manuel Cerqueiro-Gonzelez (लेखक), Elena Fernandez-Bouza (लेखक), Manuel Lorenzo Lopez- Reboiro (लेखक), Paula Pesqueira-Fontan (लेखक), Patricia Vazquez-Rodríguez (लेखक), Ignacio Novo-Veleiro (लेखक), Emilio Casariego-Vales (लेखक)
स्वरूप:	पुस्तक
प्रकाशित:	Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications, 2019-11-25.
विषय:	Research Article
ऑनलाइन पहुंच:	Connect to this object online.
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन

ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS
द्वारा: A. Y. Rychkov, और अन्य
प्रकाशित: (2016)

Topical issues of dabigatran use in combination antithrombotic therapy in patients with acute coronary syndrome and nonvalvular atrial fibrillation
द्वारा: N. A. Novikova, और अन्य
प्रकाशित: (2020)

Predictors of Thrombus Dissolution in the Left Atrial Appendage in Patients with Persistent Nonvalvular Atrial Fibrillation
द्वारा: E. S. Mazur, और अन्य
प्रकाशित: (2022)

THROMBUS OF LEFT ATRIUM AND/OR ITS APPENDAGE IN CASE OF NONVALVULAR ATRIAL FIBRILLATION: FREQUENCY OF DETECTION AND CLINICAL RISK FACTORS
द्वारा: I. A. Zaigrayev, और अन्य
प्रकाशित: (2020)

Incidence of cerebral microembolization in patients with nonvalvular atrial fibrillation using transcranial Doppler
द्वारा: Hamouda A.K.H El-Bahnasy, और अन्य
प्रकाशित: (2022)

Clinical Efficacy and Safety Comparison of Rivaroxaban and Dabigatran for Nonvalvular Atrial Fibrillation Patients Undergoing Percutaneous Left Atrial Appendage Closure Operation
द्वारा: Xiaoye Li, और अन्य
प्रकाशित: (2021)

The Rate of Clinical Outcomes in Atrial Fibrillation according to Antithrombotic Strategy: The COOL-AF Registry
द्वारा: Rungroj Krittayaphong, और अन्य
प्रकाशित: (2022)

Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation
द्वारा: V. I. Petrov, और अन्य
प्रकाशित: (2019)

APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION
द्वारा: E. A. Ushkalova, और अन्य
प्रकाशित: (2017)

Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol
द्वारा: Josep Comin Colet, और अन्य
प्रकाशित: (2023)

Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease
द्वारा: I. S. Daabul, और अन्य
प्रकाशित: (2016)

Antithrombotic Therapy in Patients with Atrial Fibrillation after Myocardial Infarction: Clinical Guidelines and Actual Practice
द्वारा: K. G. Pereverzeva, और अन्य
प्रकाशित: (2019)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
द्वारा: M. Yu. Gilyarov, और अन्य
प्रकाशित: (2016)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES
द्वारा: Ya. P. Dovgalevskiy, और अन्य
प्रकाशित: (2016)

ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS
द्वारा: M. Yu. Gilyarov, और अन्य
प्रकाशित: (2016)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
द्वारा: M. Yu. Gilyarov, और अन्य
प्रकाशित: (2016)

Analysis of antithrombotic therapy of atrial fibrillation in international and Russian registries
द्वारा: O. V. Reshetko, और अन्य
प्रकाशित: (2019)

A cross-sectional study of appropriateness evaluation of anticoagulation therapy for inpatients with nonvalvular atrial fibrillation
द्वारा: Xiao-Yuan Zheng, और अन्य
प्रकाशित: (2023)

RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE
द्वारा: I. V. Grajfer, और अन्य
प्रकाशित: (2015)

RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE
द्वारा: I. V. Grajfer, और अन्य
प्रकाशित: (2015)

EFFICACY AND SAFETY OF DIRECT ORAL ANTICOAGULANTS IN THE PREVENTION OF STROKE IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION IN EVERYDAY CLINICAL PRACTICE: FACTS ABOUT RIVAROXABAN
द्वारा: I. S. Yavelov
प्रकाशित: (2016)

Clinical practices of the management of nonvalvular atrial fibrillation and outcome of treatment: A representative prospective survey in tertiary healthcare centers across Turkey
द्वारा: Bülent Özin, और अन्य
प्रकाशित: (2018)

Antioxidant Properties of Oral Antithrombotic Therapies in Atherosclerotic Disease and Atrial Fibrillation
द्वारा: Luigi Falco, और अन्य
प्रकाशित: (2023)

ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY)
द्वारा: V. I. Petrov, और अन्य
प्रकाशित: (2015)

Antithrombotic Therapy in Patients with Paroxysmal Atrial Fibrillation after Catheter Treatment
द्वारा: O. R. Eshmatov, और अन्य
प्रकाशित: (2023)

Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
द्वारा: A. V. Panov
प्रकाशित: (2021)

ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY)
द्वारा: V. I. Petrov, और अन्य
प्रकाशित: (2015)

Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US
द्वारा: Miller JD, और अन्य
प्रकाशित: (2016)

Setting priorities in the health care sector – the case of oral anticoagulants in nonvalvular atrial fibrillation in Denmark
द्वारा: Poulsen PB, और अन्य
प्रकाशित: (2017)

Anticoagulation control among patients with nonvalvular atrial fibrillation: A single tertiary cardiac center experience
द्वारा: Shaban Mohammed, और अन्य
प्रकाशित: (2017)

The preoperative management of dabigatran and its specific antidote idarucizumab in patients with nonvalvular atrial fibrillation: Case reports
द्वारा: Tomić Milan
प्रकाशित: (2020)

Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy
द्वारा: E. S. Mazur, और अन्य
प्रकाशित: (2021)

Estimation of left atrial appendage wall motion velocity in patients with persistent nonvalvular atrial fibrillation and its effect on thrombotic risk
द्वारा: Waleed Yousof, और अन्य
प्रकाशित: (2021)

Antithrombotic alternatives for stroke prevention in atrial fibrillation: critical differences and remaining questions
द्वारा: James S Kalus
प्रकाशित: (2013)

DABIGATRAN ETEXILATE FOR PREVENTION OF CARDIOEMBOLIC COMPLICATIONS IN NONVALVULAR ATRIAL FIBRILLATION: HOW TO DO THE INTERVENTION MORE EFFECTIVE AND SAFER
द्वारा: I. S. Yavelov
प्रकाशित: (2016)

Efficacy and Safety of Direct Oral Anticoagulants in Patients with Diabetes and Nonvalvular Atrial Fibrillation: Meta-Analysis of Observational Studies
द्वारा: Bo Cao, और अन्य
प्रकाशित: (2021)

Type 2 diabetes mellitus and nonvalvular atrial fibrillation in Mexico: national registries raise a red flag
द्वारा: Manlio F. Márquez-Murillo, और अन्य
प्रकाशित: (2023)

Anticoagulation Therapy by Age and Embolic Risk for Nonvalvular Atrial Fibrillation in Mexico, an Upper-Middle-Income Country: The CARMEN-AF Registry
द्वारा: Manlio F. Márquez, और अन्य
प्रकाशित: (2020)

Thrombus of left atrium and/or its appendage in nonvalvular atrial fibrillation: echocardiographic and laboratory risk factors, capabilities for prediction and correction
द्वारा: I. A. Zaigraev, और अन्य
प्रकाशित: (2020)

Critical Appraisal of Guidelines for Antithrombotic Therapy in Atrial Fibrillation Post-Percutaneous Coronary Intervention
द्वारा: Yongqiang Fan, और अन्य
प्रकाशित: (2022)